NASDAQ:DOCS Doximity (DOCS) Stock Price, News & Analysis $40.88 +0.25 (+0.62%) (As of 09/20/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Get Doximity alerts: Email Address About Doximity Stock (NASDAQ:DOCS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Doximity alerts:Sign Up Key Stats Today's Range$40.15▼$41.0550-Day Range$25.50▼$40.8952-Week Range$19.71▼$41.05Volume2.36 million shsAverage Volume1.72 million shsMarket Capitalization$7.58 billionP/E Ratio56.78Dividend YieldN/APrice Target$32.42Consensus RatingHold Company OverviewDoximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.Read More… Our #1 Ticker for the Rare "Retirement Window" (Ad)We've only seen this happen three times in the past 20 years... And every time - like clockwork - it's minted an entire new class of millionaires.Click here for our #1 "Retirement Window" Stock >>> Doximity Stock Analysis - MarketRank™See Top Rated MarketRank™ StocksOverall MarketRank™: 68th PercentileDoximity scored higher than 68% of companies evaluated by MarketBeat, and ranked 334th out of 1,003 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.1 / 5Analyst RatingHold Consensus RatingDoximity has received a consensus rating of Hold. The company's average rating score is 2.27, and is based on 4 buy ratings, 8 hold ratings, and 2 sell ratings.Amount of Analyst CoverageDoximity has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Doximity's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth7.50% Earnings GrowthEarnings for Doximity are expected to grow by 7.50% in the coming year, from $0.80 to $0.86 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Doximity is 56.78, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 126.95.Price to Earnings Ratio vs. SectorThe P/E ratio of Doximity is 56.78, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 137.05.Price to Earnings Growth RatioDoximity has a PEG Ratio of 5.15. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDoximity has a P/B Ratio of 8.46. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Doximity's valuation and earnings. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for DOCS. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDoximity does not currently pay a dividend.Dividend GrowthDoximity does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for DOCS. News and Social Media3.2 / 5News Sentiment0.75 News SentimentDoximity has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 18 news articles for Doximity this week, compared to 7 articles on an average week.Search InterestOnly 7 people have searched for DOCS on MarketBeat in the last 30 days. This is a decrease of -36% compared to the previous 30 days.MarketBeat Follows6 people have added Doximity to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership4.2 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Doximity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,271,018.00 in company stock.Percentage Held by Insiders39.40% of the stock of Doximity is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions87.19% of the stock of Doximity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Doximity's insider trading history. Receive DOCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Doximity and its competitors with MarketBeat's FREE daily newsletter. Email Address DOCS Stock News HeadlinesDoximity Sell Rating: User Engagement and Regulatory Risks Impact Growth OutlookSeptember 21 at 11:32 AM | markets.businessinsider.comDoximity (NASDAQ:DOCS) Lifted to Strong-Buy at Baird R WSeptember 20 at 4:11 AM | americanbankingnews.comOur #1 Ticker for the Rare "Retirement Window"We've only seen this happen three times in the past 20 years... And every time - like clockwork - it's minted an entire new class of millionaires.September 22, 2024 | Behind the Markets (Ad)Doximity (NASDAQ:DOCS) Reaches New 1-Year High After Analyst UpgradeSeptember 19 at 1:33 AM | americanbankingnews.comDoximity (NASDAQ:DOCS) Given New $45.00 Price Target at Robert W. BairdSeptember 18, 2024 | americanbankingnews.comDoximity, Inc. (NASDAQ:DOCS) Receives Average Recommendation of "Hold" from BrokeragesSeptember 18, 2024 | americanbankingnews.comPeeling Back The Layers: Exploring Doximity Through Analyst InsightsSeptember 17, 2024 | benzinga.comGE Vernova To Rally Over 30%? Here Are 10 Top Analyst Forecasts For TuesdaySeptember 17, 2024 | benzinga.comSee More Headlines DOCS Stock Analysis - Frequently Asked Questions How have DOCS shares performed this year? Doximity's stock was trading at $28.04 at the beginning of the year. Since then, DOCS stock has increased by 45.8% and is now trading at $40.88. View the best growth stocks for 2024 here. How were Doximity's earnings last quarter? Doximity, Inc. (NASDAQ:DOCS) issued its quarterly earnings data on Thursday, August, 8th. The company reported $0.22 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.16 by $0.06. The firm had revenue of $126.68 million for the quarter, compared to analysts' expectations of $119.88 million. Doximity had a net margin of 32.53% and a trailing twelve-month return on equity of 19.26%. When did Doximity IPO? Doximity (DOCS) raised $501 million in an IPO on Thursday, June 24th 2021. The company issued 23,300,000 shares at $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities served as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers. Who are Doximity's major shareholders? Doximity's top institutional investors include William Blair Investment Management LLC (3.45%), Baillie Gifford & Co. (3.18%), Clearbridge Investments LLC (3.16%) and Swedbank AB (0.90%). Insiders that own company stock include Anna Bryson, Paul W Jorgensen, Craig Overpeck, Watkin Phoebe L Yang, Timothy S Cabral, Kira Scherer Wampler and Gilbert H Kliman. View institutional ownership trends. How do I buy shares of Doximity? Shares of DOCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Company Calendar Last Earnings8/08/2024Today9/22/2024Next Earnings (Estimated)11/14/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Custom computer programming services Sub-IndustryComputer Software Current SymbolNASDAQ:DOCS CUSIPN/A CIK1516513 Webwww.doximity.com Phone650-549-4330FaxN/AEmployees890Year FoundedN/APrice Target and Rating Average Stock Price Target$32.42 High Stock Price Target$45.00 Low Stock Price Target$19.00 Potential Upside/Downside-20.7%Consensus RatingHold Rating Score (0-4)2.27 Research Coverage15 Analysts Profitability EPS (Most Recent Fiscal Year)$0.72 Trailing P/E Ratio56.78 Forward P/E Ratio51.10 P/E Growth5.15Net Income$147.58 million Net Margins32.53% Pretax Margin41.30% Return on Equity19.26% Return on Assets16.37% Debt Debt-to-Equity RatioN/A Current Ratio6.72 Quick Ratio6.72 Sales & Book Value Annual Sales$493.63 million Price / Sales15.36 Cash Flow$1.02 per share Price / Cash Flow39.93 Book Value$4.83 per share Price / Book8.46Miscellaneous Outstanding Shares185,426,000Free Float112,368,000Market Cap$7.58 billion OptionableNot Optionable Beta1.27 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (NASDAQ:DOCS) was last updated on 9/22/2024 by MarketBeat.com Staff From Our PartnersMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored[SHOCKING] Crypto Document Leak…A shocking leak has revealed Japanese electronics giant Sony is now starting its own blockchain. This move ...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredJeff Bezos Just Humiliated Elon MuskThe Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next...InvestorPlace | Sponsored625,000% GainThe recent crypto correction has shaken many investors, causing panic and uncertainty. But while others are fr...Crypto Swap Profits | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Doximity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Doximity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.